Founder & Chairman Lars H. Hoie, MD PhD, Dr. Philos.
Dr. Høie has over the last three decades worked with medical opinion leaders at University Hospitals in Europe and the U.S. The resulting clinical studies have been documented in 32 international publcations in world renowned medical and nutritional journals. He has used this knowledge and underlying science to create a range of proven natural plant-based products, which aim to have a profoundly positive effect on the health of many worldwide.
Board Member, Jostein Davidsen.
Mr Davidsen, a Norwegian native, brings more than 30 years of experience from the international pharmaceutical industry, most recently serving as the Chief Executive Officer of Acino Pharma AG in Switzerland. He previously founded NYCOMED Russia – CIS, that become one of the top leaders on the Russian - CIS pharmaceutical market, which grew to 2000 employees, including own localmanufacturing in 2011 before Nycomed Pharma was acquired by Takeda Pharmaceuticals.
Mr Davidsen served after the transaction as a Corporate Officer and the Head of the Emerging Markets at Takeda Pharmaceuticals International based in Zurich Switzerland. He was in 2014 named the world’s second most influential pharma-industry leader in Emerging Markets by Scrip (the pharmaceutical international news wire).
Board Member, Per S. Thoresen.
An experienced leader with 25 years in the pharmaceutical industry. Per was Managing Director of Nycomed Pharma AS and Takeda Nycomed AS for 11 years until 2014, following 10 years as VP Human Resources in AstraZeneca.
Co- founder and Chairman of the CDMO (Contract Development & Manufacturing Organization) Curida Holding AS in Norway, Per holds the position as Chairman of Asker Produkt AS and is a board member of several companies. He holds a Master of Law from the University of Oslo, and is a Norwegian citizen.